FIELD: chemistry.
SUBSTANCE: described are novel compounds of general formula (I)
, where the value of each symbol is defined in the claim, which are ORL-1 receptor agonists.
EFFECT: improved bioavailability, based on improved metabolic stability, strong and high selectivity and can be used in medicine.
7 cl, 148 ex, 35 tbl
Title | Year | Author | Number |
---|---|---|---|
PYRROLO[2,3-c]PYRIDINE DERIVATIVES AND METHOD OF PRODUCING SAID DERIVATIVES | 2005 |
|
RU2385320C2 |
NOCICEPTIN ANALOGUES | 2002 |
|
RU2426730C2 |
7-PIPERIDINOALKYL-3,4-DIHYDROQUINOLONE DERIVATIVES, HAVING ANTAGONISTIC ACTION ON MELANIN-CONCENTRATING HORMONE (MCH) RECEPTOR | 2009 |
|
RU2498981C2 |
DERIVATIVES OF BENZIMIDAZOLE AND PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF | 2002 |
|
RU2265018C2 |
COMPOSITION OF TETRAHYDROQUINOLINES AS BROMODOMAIN BET MODIFYING AGENTS | 2014 |
|
RU2727169C2 |
MODULATORS OF ATP-BINDING CARTRIDGE TRANSPORTERS | 2005 |
|
RU2528046C2 |
PYRAZOLE DERIVATIVES APPLIED AS PROTEIN KINASE INHIBITORS | 2001 |
|
RU2340611C2 |
METHOD OF MODULATING TRANSPORTERS OF ATP-BINDING CASSETTE | 2005 |
|
RU2525115C2 |
MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | 2005 |
|
RU2556984C2 |
ATP-BINDING CASETTE TRANSPORTER MODULATORS | 2005 |
|
RU2382779C2 |
Authors
Dates
2012-05-20—Published
2008-02-28—Filed